The Journal is led with the aid of using a Managing Editor and an Editorial Board. Members are decided on to make certain numerous illustration aligned with the journal`s objectives. The team, supported with the aid of using the Editorial Office, is devoted to retaining excessive publishing standards.
Editors are chargeable for making sure articles observe the journal`s editorial policies and HEC (Higher Education Commission) Guidelines HEC Journals and Publication Policy 2024.pdf, all geared toward fostering moral publishing.
Oversee the peer review procedure and help authors and reviewers exchange timely, helpful comments.
Editors ensure that research is reviewed fairly and objectively, ignoring the authors’ gender, color, ethnicity, or religious convictions.
Throughout the review process, authors’ and reviewers’ privacy is safeguarded. The confidentiality of the article content is maintained until publication, further protecting the privacy of research participants.
The methodical review employs initial evaluation of manuscripts by internal editors for originality and quality. Those who satisfy journal requirements move on to a Double-Blind Peer Review, which protects the privacy of both authors and reviewers. The manuscript is next assessed by content specialists, and their comments determine whether it is accepted or rejected. High standards in Pharmaceutical, Clinical, Dental, Medical and Allied sciences research are maintained
Preserve editorial independence and objectivity while avoiding conflicts of interest and excessive influence on editorial judgment.
To continuously improve editorial standards and procedures, solicit feedback from writers, reviewers, and readers.
If an editor or reviewer has a conflict of interest with the authors or their institutions, they will not work on the submission.
Manuscripts containing unpublished information will not be used without the consent of the authors.
The journal will only publish research papers that adhere to its academic criteria and scope. The editor will quickly notify authors regarding decision and give reasons for rejection.
Rejected articles can be appealed by authors by providing an explanation. An internal evaluation of this appeal will be conducted before a decision is reached. At this point, revised submissions are not allowed.
The editorial team is dedicated to upholding high standards of integrity and scientific rigor in all published content. The journal adheres to the International Committee of Medical Journal Editors (ICMJE), Pakistan Medical & Dental Council (PMDC), and Higher Education Commission (HEC) plagiarism policies to address and prevent all forms of plagiarism. This policy is applied rigorously to all submitted manuscripts to ensure originality.
Turnitin software is employed to screen submissions for similarity, with an acceptable Similarity Index (SI) below 19%, as per HEC and institutional standards. Instances of plagiarism, including un credited copying or misrepresentation of original work whether ideas, text, images, or figures are not tolerated. Text recycling or reuse of sections from an author’s previous work or another’s research without proper attribution is also deemed plagiarism and is grounds for rejection.
Cases of plagiarism or publication misconduct are managed by a disciplinary committee, including the editorial board and the editor-in-chief. In confirmed cases of misconduct, the journal may contact the authors’ institutions, funding bodies, or relevant authorities for necessary action, including corrections or retractions of affected publications.
During plagiarism checks, the following items are typically excluded from similarity calculations:
Authors will be notified and urged to edit their work or include the appropriate citations if plagiarism is found at submission or at any point during the review process. If a manuscript’s similarity index is 19% or greater, it may be rejected and will need to be resubmitted with revisions.
In order for the relevant editorial offices to take the proper action, scholars are urged to report any suspected instances of plagiarism in journals, including full details.
A comprehensive inquiry will be carried out if plagiarism is discovered after the publication. Plagiarism may be noted in the publishing PDF, and authors are notified. A formal retraction could be given, depending on how serious it is.
If a manuscript has already been published in another language, authors are required to get the required copyright permissions and declare this information. If a translation is properly referenced or entirely reworded, it might be accepted.
It is forbidden for writers to replicate large portions of their own earlier work without giving credit, a practice known as self-plagiarism. However, when properly cited, referencing earlier work is permissible.
Plagiarism diminishes intellectual contributions and compromises research ethics.
The journal urges all writers to put honesty and responsibility first while creating plagiarism-free submissions.
The Committee on Publication Ethics (COPE) counts the journal as one of its members.
Only unique work that hasn’t been published or submitted anywhere else is accepted by the journal. It is required that any manuscript submitted to this journal be pulled from other publications. If discovered after publication, manuscripts that contain fraudulent or falsified data may be withdrawn.
The International Committee of Medical Journal Editors ICMJE’s Guidelines icmje-recommendations.pdf for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Pharmaceutical and Allied Sciences Journals are adhered to by this publication. These ethical standards must be followed by all authors, reviewers, and editors
Each of the mentioned authors must have agreed to be listed, approved the manuscript, and contributed significantly to the research from a scientific standpoint. Any changes to authorship must be announced and approved by all contributors, and the ICMJE Guidelines for authorship should be consulted.
Each author’s part should be reflected in the order of authorship, and the number of authors should correspond to the extent of their contributions. The number and arrangement of authors should be decided upon by the authors themselves.
The person who has made the most contribution should be the primary author or principal investigator. With agreement from all authors, the principal investigator/ author may serve as the corresponding author or assign this obligation to another author.
Approval letter from an Institutional Review Board (IRB) or Ethical Review Committee (ERC) is required for any submitted manuscript. This approval letter should be on official letterhead, along with the committee chair’s signed and stamped statement. The ERC/IRB must issue an exemption letter for studies that do not include direct human involvement.
An alternate organization that maintains similar criteria should be consulted for ethical approval if an institution does not have an ERC. Before a study can be included or published, case reports must be approved by the department head on official letterhead, confirming participant agreement.
Authors must attest to compliance with the Declaration of Helsinki and the ethical guidelines of pertinent committees when reporting research involving human participants. The name of the institutional review board (IRB), project ID, approval date, and ethics committee approval details should all be included by the authors. Unless it is absolutely necessary for the research, participant information should not be included.
Authors must get verbal or written agreement before publishing case reports that contain patient information. Unless it is supported by research relevance, identifiable information should be eliminated.
Institutional and national guidelines for the use and care of animals must be followed by the author for animal based researches and should be clearly mention in the manuscript. The International Association of Veterinary Editors’ Consensus on Animal Ethics and Welfare offers additional recommendations on animal researched
Other than plagiarism, instances of publishing misconduct shall be handled in accordance with COPE regulations https://publicationethics.org/guidance/seminar-and-webinar/handling-case-misconduct. Corrective measures, including possible revisions or retractions, shall be taken into consideration after notifying the associated author. In extreme situations, the author’s institution may be contacted, the work may be rejected, and it may be retracted. A lifetime submission ban could be imposed for repeated infractions.
Original research paper authors are required to disclose any conflicting interests pertaining to their submitted work. A “conflict of interests” statement, both financial and non-financial, must be included at the conclusion of every paper that is submitted.
In addition to disclosing any conflicting interests, editors and reviewers have the option to withdraw from peer review if they believe there may be prejudice.
Sohail University is the owner and operator of this website. The journal’s privacy policy describes how we safeguard names, email addresses, phone numbers, and other private and professional data. Any information you provide to us via the website will only be used for publishing; it will never be shared for any other purpose.
The publication of results of all randomized control trials will only be considered if the ICMJE recommendations are followed. A trial registration number will have to be provided with the manuscript and should be mentioned at the end of the abstract. The trial should have been registered prospectively. Retrospective registration will not be considered. If the Trial was conducted without registration, the article will not be accepted for processing. Pilot studies of clinical trials will not be considered in the category of RCT or an original article.
The journal acknowledges the growing impact of technology aided by artificial intelligence (AI) on research and manuscript production. In accordance with the guidelines established by the COPE and the ICMJE, journal has adopted the following policy regarding the use of AI in published studies.
To preserve the honesty and ingenuousness of research published in Journal authors are urged to follow these rules.
This journal accepts and publishes submissions in accordance with the standards set forth by the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE).
Authorship Requirements
Every paper the magazine publishes is immediately available for reading, downloading, and sharing because it is entirely open access. The content may be copied, distributed, remixed, altered, and expanded upon by authors and readers for any reason, including profit.
In order to guarantee the authenticity and caliber of its published articles, the “Journal for Research in Pharmaceutical & Allied Sciences”, maintains a strict review policy. By using a Double-Blind Peer Review mechanism, JRPAS ensures that reviewers and writers remain anonymous throughout the evaluation process. Editorial officers take great care to protect the privacy of manuscript identities, making sure that any information that could identify the author is eliminated before to review. For all submissions, JRPAS maintains the anonymity of the author and reviewer during the review process by implementing a double-blind peer review protocol.
To maintain confidentiality, the cover letter contains all of the reviewer’s comments and criticism about the manuscripts, as well as the author’s response to those comments. Although acknowledging all contributors is advised, the blind peer review protocol must be followed and the information must only be disclosed in the cover letter to protect confidentiality. The staff editors give exceptional reading to the papers submitted to JRPAS. Only papers that satisfy the editorial standards including those submitted to national and international reviewers are forwarded for formal review. Between reviews, authors are encouraged to make necessary improvements in response to the first reviewer’s feedback before submitting to the second reviewer. However, the identification remains confidential and does not reveal to both ends.
Manuscripts that do not comply with the editors’ evaluation guidelines will be sent back to the author because they don’t contain enough information or aren’t related to the journal’s interests; otherwise, objectionable content will be immediately prohibited without outside review.
In order to follow the double-blind peer review protocol, the editor must protect authors’ anonymity and remove their information before sending the articles to the reviewer. Additionally, it is verified that every article is evaluated through extremely professional and nondiscriminatory means. Additionally, editor offer authors the reviewers’ remarks as soon as possible, giving them plenty of opportunity to make any necessary revisions.
The Open Journal System (OJS), a database, is used to maintain and practice all of the aforementioned activities. Each article is subjected to a thorough evaluation by both national and international reviewers. Each reviewer receives and submits articles from the Editorial Team via the Open Journal System database.
Because this publication employs a double-blind review process, the identity of the authors and reviewers are kept secret from one another during the review process.
Summarize your business so the visitor can learn about your offerings from any page on your website.
© All Rights Reserved.